Parabricks
Parabricks provides high performance genomic analysis that can analyze whole human genome under an hour compared to days. Using state-of-the-art GPU acceleration and machine learning, users can significantly increase the throughput of their centers. By providing patient treatment based on their genomic variations, such personalized treatment will transform healthcare practices.
Parabricks
Parabricks provides high performance genomic analysis that can analyze whole human genome under an hour compared to days. Using state-of-the-art GPU acceleration and machine learning, users can significantly increase the throughput of their centers. By providing patient treatment based on their genomic variations, such personalized treatment will transform healthcare practices.
TL;DR
What they do: GPU-accelerated genomics software for fast whole-genome secondary analysis
Founded: Around 2015–2016 as a University of Michigan spin-off
Exit: Acquired by NVIDIA (announced December 2019)
Notable funder: U.S. National Science Foundation (grants)
Company Overview
Problem Domain
High-performance genomics / bioinformatics (secondary analysis of next-generation sequencing data).
Founded
2015
Industry
Genomics / Bioinformatics / Healthtech
Tech Stack
Funding Track Record
Grant listed on Crunchbase as latest funding before acquisition.
Investor Signal
“National Science Foundation”